Position in COGT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$88,570,094
-$82,096,644 QoQ
Shares Held
2,288,633
-48.4% QoQ
Ownership
1.32%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#22
of 321 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. COGT ranks #41 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in COGT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,570,094 | 2,288,633 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $170,666,738 | 4,434,054 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $60,566,714 | 1,705,144 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $23,832,961 | 1,659,677 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,619,137 | 1,200,437 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,923,882 | 988,962 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $6,746,165 | 864,893 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $9,482,799 | 878,037 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,330,887 | 513,747 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,854,443 | 871,197 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,627,018 | 446,772 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $3,898,849 | 399,882 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $4,319,634 | 364,834 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $5,974,745 | 553,730 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $7,464,719 | 645,737 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $11,070,460 | 741,988 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $3,336,723 | 369,925 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,340,956 | 179,033 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $679,184 | 79,159 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,258,917 | 149,693 | Shares | Defined | 2022-01-20 | |
| 2021-03-31 | $341,383 | 38,882 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $115,814 | 10,313 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 UMRX | — | 32,500 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 UMRX | — | 41,718 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 UMRX | — | 41,718 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||